Although no pathogenic MSH2 mutation was present in the newly established CRC cell lines, the protein expression of MSH2 was varying, which implicated the protein expression of MSH2 was determined by RNA splicing or epigenetical alternations (Fig. 2a). This evidence concerns the gene MSH2 and colorectal carcinoma.